Evidence map›Paper›PMID 31440502›Full record

ArticleFrontiers in bioengineering and biotechnology2019

Synthesis of Dextran-Phenoxodiol and Evaluation of Its Physical Stability and Biological Activity.

Eugene M H Yee, Giuseppe Cirillo, Miriam B Brandl, David StC Black, Orazio Vittorio, Naresh Kumar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. The role of PI3K/AKT signaling pathway in gallbladder carcinoma.American journal of translational research · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Eugene M H YeeSchool of Chemistry, University of New South Wales, Sydney, NSW, Australia.
Giuseppe CirilloDepartment of Pharmacy Health and Nutritional Sciences, University of Calabria, Rende, Italy.
Miriam B BrandlLowy Cancer Research Centre, Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
David StC BlackSchool of Chemistry, University of New South Wales, Sydney, NSW, Australia.
Orazio VittorioLowy Cancer Research Centre, Children's Cancer Institute, University of New South Wales, Sydney, NSW, Australia.
Naresh KumarSchool of Chemistry, University of New South Wales, Sydney, NSW, Australia.
UNSW Sydney · AUCancer Institute of New South Wales · AUUniversity of Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phenoxodiol, an isoflavene anti-tumor agent, was conjugated on the polysaccharide dextran using immobilized laccase as biocatalyst. The success of the enzymatic conjugation was determined by UV-vis spectrophotometry and its functionalization degree was assessed by

Indexed as

anti-angiogenicanti-tumorconjugatedextranphenoxodiol

Identifiers

PMID31440502
PMCPMC6694440
OpenAlexW2956215661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.